Altitude Pharma Inc shares physical facilities and some senior management in common with another firm (with a different DUNS number) that does not appear to be SBIR involved. With overlapping technology focus, the latter firm was also launched in the same year (2013) by by a group of executives from San Diegos Elevation Pharmaceuticals, which had been acquired in 2012 for $430 million by Sunovion Pharmaceuticals. Additionally, the non-SBIR funded firm has successfuly also raised over $44M in VC in four rounds while Altitude has no recorded VC transactions. The no-SBIR involved firm is organized arouns Patara Pharma is a clinical-stage biopharmaceutical company significantly improving the lives of patients suffering from chronic inflammation and fibrosis.
